Effective open-label treatment of tourette's disorder with olanzapine.

@article{Stamenkovic2000EffectiveOT,
  title={Effective open-label treatment of tourette's disorder with olanzapine.},
  author={Mara Stamenkovic and Shird Dieter Schindler and Harald Nikolaus Aschauer and Martina de Zwaan and Ulrike Willinger and E Resinger and Siegfried Kasper},
  journal={International clinical psychopharmacology},
  year={2000},
  volume={15 1},
  pages={23-8}
}
Olanzapine is an atypical antipsychotic drug which shows a high antagonistic affinity to the D1, D2 and D4 and the 5-HT2A and 5-HT2c receptors. The goal of our investigation was to assess the efficacy of olanzapine in patients with Tourette's disorder who were either antipsychotic naive or who did not tolerate and/or did not respond to previous antipsychotic treatments in an open-label pilot study. Fourteen patients with a mean (SD 12.4) age of 32.6 years were treated for a period of 6 weeks… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Olanzapine treatment for tics in an adult woman with severe tourette syndrome.

Acta neurologica Taiwanica • 2012
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…